RFXANK Polyclonal Antibody, Invitrogen™
Manufacturer: Thermo Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | PIPA5112212-Each-of-1 | In Stock | ₹ 43,120.50 |
PIPA5112212 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 43,120.50
GST (18%): ₹ 7,761.69
Total Price: ₹ 50,882.19
Antigen
RFXANK
Classification
Polyclonal
Conjugate
Unconjugated
Gene
RFXANK
Gene Alias
ANKRA1; Ankyrin repeat family A protein 1; ankyrin repeat-containing regulatory factor X-associated protein; BLS; DNA-binding protein RFXANK; F14150_1; regulatory factor X associated ankyrin containing protein; regulatory factor X subunit B; Regulatory factor X-associated ankyrin-containing protein; RFXANK; RFXB; RFX-B; RFX-Bdelta4
Host Species
Rabbit
Purification Method
Antigen affinity chromatography, Protein A
Regulatory Status
RUO
Gene ID (Entrez)
8625
Content And Storage
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Form
Liquid
Applications
Immunoprecipitation, Western Blot
Concentration
1 mg/mL
Formulation
PBS with 0.03% ProClin 300; pH 7
Gene Accession No.
O14593
Gene Symbols
RFXANK
Immunogen
E. coli-derived Human RFXANK fragment
Quantity
100 μL
Primary or Secondary
Primary
Target Species
Human
Product Type
Antibody
Isotype
IgG
Related Products
Description
- Major histocompatibility (MHC) class II molecules are transmembrane proteins that have a central role in development and control of the immune system
- The protein encoded by this gene, along with regulatory factor X-associated protein and regulatory factor-5, forms a complex that binds to the X box motif of certain MHC class II gene promoters and activates their transcription
- Once bound to the promoter, this complex associates with the non-DNA-binding factor MHC class II transactivator, which controls the cell type specificity and inducibility of MHC class II gene expression
- This protein contains ankyrin repeats involved in protein-protein interactions
- Mutations in this gene have been linked to bare lymphocyte syndrome type II, complementation group B
- Two transcript variants encoding different isoforms have been described for this gene, with only one isoform showing activation activity.